Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine
1996

Tumour-targeting properties of a new zinc phthalocyanine

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): C Ometto, C Fabris, C Milanesi, G Jori, MJ Cook, DA Russell

Primary Institution: Department of Biology, University of Padua, Italy; School of Chemical Sciences, University of East Anglia, UK

Hypothesis

Does the novel zinc(II) octadecylphthalocyanine (ZnODPc) have effective tumour-localising and photosensitising properties?

Conclusion

ZnODPc shows high efficiency and selectivity for tumour targeting and induces significant tumour necrosis through multiple mechanisms.

Supporting Evidence

  • ZnODPc showed a high affinity for serum low-density lipoproteins.
  • The maximum accumulation in the tumour occurred at 24 hours after injection.
  • Low amounts of phthalocyanine were recovered from skin, indicating minimal side effects.
  • Electron microscopy revealed significant structural damage to tumour cells post-treatment.
  • Apoptosis was observed in tumour cells after photodynamic therapy with ZnODPc.

Takeaway

A new drug called ZnODPc can find and attack cancer cells really well, helping to shrink tumors when used with light.

Methodology

The study involved injecting different doses of ZnODPc into mice with fibrosarcoma and measuring its accumulation in tissues over time.

Limitations

The study was limited to a one-week observation period due to the rapid growth of the tumours.

Participant Demographics

Female Balb/c mice, 20-22 g body weight.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication